191 related articles for article (PubMed ID: 36983232)
1. Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure.
Berezina TA; Obradovic Z; Boxhammer E; Berezin AA; Lichtenauer M; Berezin AE
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983232
[TBL] [Abstract][Full Text] [Related]
2. The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure.
Berezin AA; Obradovic Z; Fushtey IM; Berezina TA; Novikov EV; Schmidbauer L; Lichtenauer M; Berezin AE
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36830993
[TBL] [Abstract][Full Text] [Related]
3. Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index.
Zang H; Jiang F; Cheng X; Xu H; Hu X
Endocr J; 2018 Jul; 65(7):685-691. PubMed ID: 29669965
[TBL] [Abstract][Full Text] [Related]
4. Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart Failure.
Berezin AA; Obradovic Z; Novikov EV; Boxhammer E; Lichtenauer M; Berezin AE
Diagnostics (Basel); 2022 Nov; 12(12):. PubMed ID: 36552947
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus.
Berezin AA; Fushtey IM; Pavlov SV; Berezin AE
Mol Biomed; 2022 Nov; 3(1):34. PubMed ID: 36350412
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Adropin and Afamin in Evaluating Renal Function and Cardiovascular Health in the Presence of CKD-MBD Biomarkers in Chronic Kidney Disease.
Kaur R; Krishan P; Kumari P; Singh T; Singh V; Singh R; Ahmad SF
Diagnostics (Basel); 2023 Oct; 13(19):. PubMed ID: 37835901
[TBL] [Abstract][Full Text] [Related]
7. Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients.
Li B; Tian X; Guo S; Zhang M; Li J; Zhai N; Wang H; Zhang Y
Int Urol Nephrol; 2020 Nov; 52(11):2145-2152. PubMed ID: 32661627
[TBL] [Abstract][Full Text] [Related]
8. The association between serum adropin and carotid atherosclerosis in patients with type 2 diabetes mellitus: a cross‑sectional study.
Wei W; Liu H; Qiu X; Zhang J; Huang J; Chen H; Qiu S; Lin R; Li S; Tu M
Diabetol Metab Syndr; 2022 Feb; 14(1):27. PubMed ID: 35135590
[TBL] [Abstract][Full Text] [Related]
9. A STUDY OF THE ASSESSMENT OF SERUM ADROPIN LEVEL AS A RISK FACTOR OF ISCHAEMIC HEART DISEASE IN TYPE 2 DIABETES MELLITUS CASES.
Mansour HK; Makboul K; Elhalawany SH; Ibrahim BE; Marawan DA
Georgian Med News; 2022; (328-329):115-117. PubMed ID: 36318853
[TBL] [Abstract][Full Text] [Related]
10. Role of rs7903146 polymorphism and adropin serum level in patients with diabetes mellitus; a case-control study from Isfahan, Iran.
Palizban AA; Yazdani AH; Jahanbani-Ardakani H
Arch Physiol Biochem; 2022 Apr; 128(2):378-381. PubMed ID: 31818149
[TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease begets heart failure and vice versa: temporal associations between heart failure events in relation to incident chronic kidney disease in type 2 diabetes.
Wu MZ; Teng TK; Tay WT; Ren QW; Tromp J; Ouwerkerk W; Chandramouli C; Huang JY; Chan YH; Teramoto K; Yu SY; Lawson C; Li HL; Tse YK; Li XL; Hung D; Tse HF; Lam CSP; Yiu KH
Diabetes Obes Metab; 2023 Mar; 25(3):707-715. PubMed ID: 36346045
[TBL] [Abstract][Full Text] [Related]
12. Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure.
Berezin AA; Obradovic AB; Fushtey IM; Berezina TA; Lichtenauer M; Berezin AE
J Cardiovasc Dev Dis; 2023 Mar; 10(4):. PubMed ID: 37103015
[TBL] [Abstract][Full Text] [Related]
13. Serum Adropin as a Potential Biomarker for Predicting the Development of Type 2 Diabetes Mellitus in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease.
Li N; Xie G; Zhou B; Qu A; Meng H; Liu J; Wang G
Front Physiol; 2021; 12():696163. PubMed ID: 34366886
[No Abstract] [Full Text] [Related]
14. Longitudinal changes in serum adropin levels and liver fat content during liraglutide treatment in newly diagnosed patients with type 2 diabetes mellitus and metabolic dysfunction-associated fatty liver disease.
Zhang L; Wu X; Li X; Chang X; Ding X; Wang Q; Jiang T; Wang G; Liu J
Acta Diabetol; 2023 Jul; 60(7):971-979. PubMed ID: 37079136
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Value of Serum Adropin Level in Early Detection of Diabetic Nephropathy.
Es-Haghi A; Al-Abyadh T; Mehrad-Majd H
Kidney Blood Press Res; 2021; 46(6):734-740. PubMed ID: 34644709
[TBL] [Abstract][Full Text] [Related]
16. Association of Serum Adropin Concentrations with Diabetic Nephropathy.
Hu W; Chen L
Mediators Inflamm; 2016; 2016():6038261. PubMed ID: 27546995
[TBL] [Abstract][Full Text] [Related]
17. Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus.
Berezin AA; Lichtenauer M; Boxhammer E; Stöhr E; Berezin AE
Cells; 2022 Sep; 11(18):. PubMed ID: 36139374
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of adropin and diabetes: a systematic review and meta-analysis of observational studies.
Soltani S; Beigrezaei S; Malekahmadi M; Clark CCT; Abdollahi S
BMC Endocr Disord; 2023 Apr; 23(1):73. PubMed ID: 37029398
[TBL] [Abstract][Full Text] [Related]
19. Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus.
Cherney DZI; Repetto E; Wheeler DC; Arnold SV; MacLachlan S; Hunt PR; Chen H; Vora J; Kosiborod M
Am J Nephrol; 2020; 51(1):74-82. PubMed ID: 31812955
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma levels of adropin in heart failure patients.
Lian W; Gu X; Qin Y; Zheng X
Intern Med; 2011; 50(15):1523-7. PubMed ID: 21804276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
